The FDA is reclassifying interventional cardiovascular implant simulation software into the class II (special controls) regulatory category, which will make it easier for the technology to pass regulatory approval. 

The FDA has cleared Polarean Imaging’s xenon gas-based MRI contrast agent for evaluating pulmonary function in patients aged 12 years and up.

A new clinical trial in Australia is one of the largest in the world to use brain imaging to test the impact of psychedelics on neural activity.

The NRC noted that advancements in nuclear medicine and increased use of radiopharmaceuticals prompted the commission to reconsider the exclusion of extravasation from medical event reporting.  

American Society of Nuclear Cardiology (ASNC) 2023 President Mouaz H. Al-Mallah, MD, said the subspecialty needs to up its game with new technology.

A neurologist who examined the patient's imaging explained that her brain swelling was so severe in some cases that the folds of the cerebral cortex appeared “merged and squashed.”

Pediatric cardiologist Takeshi Tsuda, MD, discussed the evaluation of cardiotoxicity in young cancer patients at the American Heart Association (AHA) 2022 meeting.

A population-level study featuring multi-organ MRI has confirmed that problems in any of three major organs—the heart, brain or liver—tend to co-occur with unfavorable findings in either or both of the other two.